首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >A study on treatment outcome and adverse drug reactions among extra pulmonary tuberculosis patients treated under DOTS in a tertiary care hospital
【24h】

A study on treatment outcome and adverse drug reactions among extra pulmonary tuberculosis patients treated under DOTS in a tertiary care hospital

机译:三级医院接受DOTS治疗的额外肺结核患者的治疗结果和药物不良反应的研究

获取原文
           

摘要

Background: Pulmonary tuberculosis being the predominant manifestation of the disease Extra-Pulmonary sites can also involve as a result of dissemination from a chief focus. The present study aims to determine the presentation and outcome of patients with extra-pulmonary tuberculosis treated with category I DOTS and to identify the incidence and pattern of ADRs caused by anti-tubercular drugs and to assess the causality and severity of the reported ADRs. Methods: Data was collected from cases of Tuberculosis patients diagnosed and treated under category I DOTS at Sri Siddhartha Medical College for the period of one year (during 2015). These patients were monitored for ADRs during OPDs and hospital stay. Any Adverse effects observed were recorded in ‘Adverse Drug Event Reporting Form’ prepared by the CDSCO, Govt. of India. The data were evaluated for patient demography, types of TB, incidence of ADRs, onset and outcome of the ADRs. ADRs were also assessed for their causality and severity by using WHO-UMC criteria and Hartwig’s scale. Results: Extra-pulmonary cases accounted for 32.2% of total TB cases. Among 224 cases of extra-pulmonary TB studied, 136 (60.7%) were males and 88 (39.3%) were females. Among these patients 82.2% completed treatment, 7.5% were defaulted, 9.9% died and 0.4% treatment failure. The most common reason for default was irregular treatment (29.5%) followed by alcohol abuse (23.5%). Among 224 patients of EPTB who were started on ATT as per DOTS, we noted ADR in 52 patients and 73 ADRs. Gastritis was the most common ADR (25%) followed by anorexia (14%) and skin reactions (9.6%) and multiple drug therapy was the major predisposing factor for these ADR’s. Conclusions: Extra-pulmonary Tuberculosis accounts for 32.2% of the total cases studied. Treatment irregularities and alcohol abuse are the two most common reasons for default. On evaluation of the causality of ADRs, majority of them were found to be ‘possible’ by WHO-UMC and Naronjo’s causality assessment scale. The severity assessment of ADRs showed that 42% reactions were moderate and 58% were of the ‘mild’ nature.
机译:背景:肺结核是该疾病的主要表现形式。从主要重点进行传播的结果还可能涉及肺外部位。本研究旨在确定接受I类DOTS治疗的肺外结核患者的表现和结局,并确定由抗结核药物引起的ADR的发生率和类型,并评估所报告ADR的因果关系和严重程度。方法:数据收集自斯里兰卡悉达多医学院为期一年(2015年)诊断为I DOTS类别的结核病患者。在OPD和住院期间对这些患者进行ADR监测。观察到的任何不良反应都记录在CDSCO政府制定的“药品不良事件报告表”中。印度。对数据进行了患者人口统计学,结核病类型,ADR发生率,ADR发作和预后的评估。还使用WHO-UMC标准和Hartwig量表评估了ADR的因果关系和严重程度。结果:肺外病例占总结核病病例的32.2%。在研究的224例肺外结核病例中,男性136例(60.7%),女性88例(39.3%)。在这些患者中,完成治疗的占82.2%,违约的占7.5%,死亡的占9.9%,治疗失败的占0.4%。违约的最常见原因是不规则治疗(29.5%),其次是酗酒(23.5%)。在根据DOTS开始接受ATT的224例EPTB患者中,我们注意到52例患者和73例ADR发生了ADR。胃炎是最常见的ADR(25%),其次是厌食(14%)和皮肤反应(9.6%),多种药物治疗是导致这些ADR的主要诱因。结论:肺外结核占研究病例总数的32.2%。治疗不规范和酗酒是违约的两个最常见原因。在对ADR的因果关系进行评估时,WHO-UMC和Naronjo的因果关系评估量表发现其中大多数是“可能的”。对ADR的严重程度评估表明,有42%的反应属于中度反应,而58%的反应属于“轻度”反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号